← Back to trade feed
AMGN Buy
Cliff BentzRepublican · OR-2 · HouseTraded Jun 6, 2025Notified Jul 1, 2025
Trade details
| Amount | $1,001 – $15,000 |
| Asset | SP Amgen Inc. - Common Stock (AMGN) [ST] (ST) |
| Issuer | AMGEN INC |
| Disclosure | 2025 PTR |
What happened next
Stock performance after the trade and after the disclosure became public, compared with SPY, an S&P 500 ETF.
Historical market data is not connected yet.
Conflict Score
65
Direct jurisdiction
Committee–industry overlap. The explanation and original filing are available below.
Why this score
- Rep. Cliff Bentz (R-OR) sits on the HSIF, whose jurisdiction covers: health, pharma.
- AMGEN INC (SIC 2836: Biological Products, (No Diagnostic Substances)) maps to the health, pharma domains, placing it under that committee's direct oversight.
Powered by the base rules engine. Modifiers (trade size, timing, owner, options) are layered in a later release.
What do the scores mean? Committee–industry overlap
- 65
- Direct jurisdiction
- 50
- Subcommittee
- 30
- Sector overlap
- 18
- Broad jurisdiction
- 0
- No mapped overlap
- —
- Not scored · missing data
The current base model tops out at 65 on a reserved 0–100 scale. Scores are not probabilities or findings of wrongdoing. Zero means no overlap in our mapping, not an absence of all possible conflicts. Read the methodology →
Original extracted asset text
Amount Cap. Gains > SP Amgen Inc. - Common Stock (AMGN) [ST]
Extraction may include form headers. The linked original filing is authoritative.